Risankizumab: Injection 150 mg in 1 mL pre-filled syringe, Injection 150 mg in 1 mL pre-filled pen; Skyrizi® Page last updated: 1 March 2024 Public Summary Document (PSD) November 2023 PBAC Meeting - (PDF 841KB) Public Summary Document (PSD) November 2023 PBAC Meeting - (Word 259KB)